Data / Drug companies / Montelukast sodium
Montelukast sodium: 31 companies and 73 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Montelukast sodium is listed in the FDA National Drug Code Directory by 31 companies, with 73 products in commercial distribution. 69 of the products (94.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, chewable; tablet, film coated; tablet, and the newest product started marketing on September 14, 2026.
The request: Get every company that lists montelukast sodium in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 31
- Products
- 73
- Generic (ANDA) products
- 69 (94.5%)
- Application numbers
- 23
- Routes
- Oral
- Brand names
- Singulair, Montelukast
- openFDA record search
- api.fda.gov
Companies that list montelukast sodium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Proficient Rx LP | 6 | tablet, chewable; tablet, film coated | Generic drugs (ANDA) | November 10, 2015 |
| A-S Medication Solutions | 5 | tablet, chewable; tablet, film coated | Generic drugs (ANDA) | May 27, 2015 |
| Organon LLC | 4 | tablet, chewable; granule | New drug applications (NDA) | June 1, 2021 |
| Torrent Pharmaceuticals Limited | 4 | tablet, chewable; tablet | Generic drugs (ANDA) | March 30, 2017 |
| Ajanta Pharma USA Inc. | 3 | granule; tablet, coated | Generic drugs (ANDA) | August 13, 2015 |
| Aurobindo Pharma Limited | 3 | tablet, chewable; tablet, film coated | Generic drugs (ANDA) | August 3, 2012 |
| Bryant Ranch Prepack | 3 | tablet, film coated; tablet, chewable | Generic drugs (ANDA) | January 1, 2016 |
| Camber Pharmaceuticals, Inc. | 3 | tablet, chewable; tablet, film coated | Generic drugs (ANDA) | May 27, 2015 |
| Dr. Reddy's Laboratories Limited | 3 | tablet, chewable; tablet, coated | Generic drugs (ANDA) | August 6, 2012 |
| NuCare Pharmaceuticals,Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | January 1, 2016 |
| Preferred Pharmaceuticals Inc. | 3 | tablet; tablet, chewable | Generic drugs (ANDA) | March 28, 2024 |
| Proficient Rx LP | 3 | tablet, film coated; tablet, chewable | Generic drugs (ANDA) | January 1, 2016 |
| Rising Pharma Holdings, Inc. | 3 | tablet, chewable; tablet, film coated | Generic drugs (ANDA) | August 3, 2012 |
| Unichem Pharmaceuticals (USA), Inc. | 3 | tablet, chewable; tablet, film coated | Generic drugs (ANDA) | August 20, 2018 |
| AvKARE | 2 | tablet, chewable | Generic drugs (ANDA) | January 4, 2013 |
| AvPAK | 2 | tablet, chewable | Generic drugs (ANDA) | November 12, 2014 |
| Chartwell RX, LLC | 2 | tablet, chewable | Generic drugs (ANDA) | August 3, 2012 |
| Direct_Rx | 2 | tablet, film coated; tablet, chewable | Generic drugs (ANDA) | February 2, 2023 |
| Lannett Company, Inc. | 2 | tablet, chewable | Generic drugs (ANDA) | August 3, 2012 |
| Macleods Pharmaceuticals Limited | 2 | tablet, chewable | Generic drugs (ANDA) | March 13, 2015 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet, film coated; tablet, chewable | Generic drugs (ANDA) | April 11, 2013 |
| Accord Healthcare Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | April 11, 2013 |
| American Health Packaging | 1 | tablet, coated | Generic drugs (ANDA) | April 2, 2015 |
| Aurobindo Pharma Limited | 1 | granule | Generic drugs (ANDA) | February 18, 2020 |
| Cardinal Health 107, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | September 10, 2014 |
| Major Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | September 10, 2014 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | August 3, 2012 |
| Redpharm Drug | 1 | tablet, film coated | Generic drugs (ANDA) | April 11, 2013 |
| Remedyrepack Inc. | 1 | tablet | Generic drugs (ANDA) | September 14, 2026 |
| Rising Pharma Holdings, Inc. | 1 | tablet | Generic drugs (ANDA) | June 1, 2023 |
| Westminster Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | May 30, 2016 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 37 | 50.7% |
| Tablet, film coated | 22 | 30.1% |
| Tablet | 6 | 8.2% |
| Granule | 4 | 5.5% |
| Tablet, coated | 4 | 5.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 69 | 94.5% |
| New drug applications (NDA) | 4 | 5.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Leukotriene Receptor Antagonist | 73 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.